Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Genentech | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Genentech | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 10 hours ago
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
1 day ago
Conditions: Locally Advanced Pancreatic Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage II Pancreatic Cancer...
Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
1 day ago
Conditions: Lymphocytic Leukemia Interventions: Drug: Mosunetuzumab Sponsors: M.D. Anderson Cancer Center; Genentech...
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
1 day ago
Conditions: Lupus Nephritis; Membranous Nephropathy Interventions: Drug: Obinutuzumab Sponsors: Assistance Publique -...
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
2 days ago
Conditions: Head and Neck Cancer Interventions: Drug: Docetaxel; Drug: OSI-774; Drug: Cisplatin...
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
2 days ago
Conditions: Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma...
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
2 days ago
Conditions: Neovascular Age-related Macular Degeneration Interventions: Device: Susvimo PDS Implant; Drug: Ranibizumab...
Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
4 days ago
Conditions: Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome Interventions: Drug: Decitabine and Cedazuridine; Drug...
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
4 days ago
Conditions: Systemic Lupus Erythematosus Interventions: Biological: P-CD19CD20-ALLO1 Cells; Drug: Cyclophosphamide; Drug: Fludarabine...
A Dose-Escalation Study of RO7875913 in Healthy Participants
4 days ago
Conditions: Healthy Volunteers Interventions: Drug: RO7875913; Drug: Placebo Sponsors: Genentech, Inc. Recruiting
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
4 days ago
Conditions: Early Breast Cancer Interventions: Drug: Giredestrant Sponsors: Genentech, Inc. Recruiting
A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
4 days ago
Conditions: Relapsed/Refractory Multiple Myeloma Interventions: Drug: RO7851624 Sponsors: Genentech, Inc. Recruiting
Ocrevus Zunovo for MS: Mixed Methods
4 days ago
Conditions: Multiple Sclerosis Interventions: Other: Clinical Questionnaires; Other: Semi-Structured Interviews; Drug: Ocrevus...